$COEP
Coeptis Therapeutics Holdings, Inc.

2024 Q4 Form 10-Q Financial Statement

#000168316824007980 Filed on November 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $173.1K $2.828M
YoY Change -93.88% -48.5%
% of Gross Profit
Research & Development $811.8K $4.983M
YoY Change -83.71% 23758.62%
% of Gross Profit
Depreciation & Amortization $250.0K
YoY Change
% of Gross Profit
Operating Expenses $2.142M $7.831M
YoY Change -72.65% 1340.5%
Operating Profit -$2.142M -$7.831M
YoY Change -72.65% 1340.49%
Interest Expense $19.80K
YoY Change -86.42%
% of Operating Profit
Other Income/Expense, Net $312.9K $1.571M
YoY Change -80.08% 1593.1%
Pretax Income -$1.829M -$6.261M
YoY Change -70.79% 1952.02%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.829M -$6.261M
YoY Change -70.79% 1952.04%
Net Earnings / Revenue
Basic Earnings Per Share -$0.05 -$0.23
Diluted Earnings Per Share -$0.05 -$0.23
COMMON SHARES
Basic Shares Outstanding 41.12M shares 39.72M shares 25.14M shares
Diluted Shares Outstanding 39.81M shares 26.65M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.410M
YoY Change 10095.23%
Cash & Equivalents $1.137M $1.412M
Short-Term Investments
Other Short-Term Assets $210.0K
YoY Change 1125.2%
Inventory
Prepaid Expenses $227.2K $208.1K
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $1.365M $4.120M
YoY Change -66.88% 13206.02%
LONG-TERM ASSETS
Property, Plant & Equipment $10.67K $11.62K
YoY Change -8.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.010M
YoY Change
Total Long-Term Assets $7.591M $3.050M
YoY Change 148.87% -90.83%
TOTAL ASSETS
Total Short-Term Assets $1.365M $4.120M
Total Long-Term Assets $7.591M $3.050M
Total Assets $8.956M $7.171M
YoY Change 24.9% -78.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.134M $482.0K
YoY Change 135.32% -65.58%
Accrued Expenses $742.2K $298.3K
YoY Change 148.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change -100.0%
Long-Term Debt Due $830.0K
YoY Change
Total Short-Term Liabilities $3.440M $1.616M
YoY Change 112.88% -14.68%
LONG-TERM LIABILITIES
Long-Term Debt $150.0K $150.0K
YoY Change 0.0%
Other Long-Term Liabilities $390.0K
YoY Change -85.56%
Total Long-Term Liabilities $533.3K $543.1K
YoY Change -1.8% -79.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.440M $1.616M
Total Long-Term Liabilities $533.3K $543.1K
Total Liabilities $3.974M $2.159M
YoY Change 84.04% -53.0%
SHAREHOLDERS EQUITY
Retained Earnings -$95.22M -$82.98M
YoY Change 14.75% 1680.87%
Common Stock $3.997K $3.299K
YoY Change 21.16% -86.8%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00
YoY Change
Treasury Stock Shares
Shareholders Equity $4.825M $5.012M
YoY Change
Total Liabilities & Shareholders Equity $8.956M $7.171M
YoY Change 24.9% -78.47%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$1.829M -$6.261M
YoY Change -70.79% 1952.04%
Depreciation, Depletion And Amortization $250.0K
YoY Change
Cash From Operating Activities -$1.960M
YoY Change 2686.86%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $350.0K
YoY Change -362.51%
Cash From Investing Activities $350.0K
YoY Change -362.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -220.0K
YoY Change -265.0%
NET CHANGE
Cash From Operating Activities -1.960M
Cash From Investing Activities 350.0K
Cash From Financing Activities -220.0K
Net Change In Cash -1.830M
YoY Change 2502.02%
FREE CASH FLOW
Cash From Operating Activities -$1.960M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Cash
Cash
1137453 usd
CY2023Q4 us-gaap Cash
Cash
1469134 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001759186
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
241601 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1749713 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25237 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13931 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11306 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-87356260 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
813964 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
0 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
813964 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4571089 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1550724 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
26627 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1828914 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7865647 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-6350494 usd
us-gaap Profit Loss
ProfitLoss
-7865647 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1828914 usd
us-gaap Net Income Loss
NetIncomeLoss
-7865647 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-6350494 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 coep Shares Issued In Exchange For Subscription Receivable
SharesIssuedInExchangeForSubscriptionReceivable
usd
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39669
dei Entity Registrant Name
EntityRegistrantName
COEPTIS THERAPEUTICS HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1465952
dei Entity Address Address Line1
EntityAddressAddressLine1
105 Bradford Rd
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 420
dei Entity Address City Or Town
EntityAddressCityOrTown
Wexford
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
15090
dei City Area Code
CityAreaCode
724
dei Local Phone Number
LocalPhoneNumber
934-6467
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
41118593 shares
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
CY2024Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
0 usd
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
38978 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
227221 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
1364674 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25237 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14565 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10672 usd
CY2024Q3 us-gaap Investments
Investments
5691084 usd
CY2023Q4 us-gaap Investments
Investments
0 usd
CY2024Q3 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
15833 usd
CY2023Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
158333 usd
CY2024Q3 us-gaap Finite Lived Contractual Rights Gross
FiniteLivedContractualRightsGross
1804167 usd
CY2023Q4 us-gaap Finite Lived Contractual Rights Gross
FiniteLivedContractualRightsGross
2554166 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
69554 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
97571 usd
CY2024Q3 us-gaap Other Assets
OtherAssets
7580638 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
2810070 usd
CY2024Q3 us-gaap Assets
Assets
8955984 usd
CY2023Q4 us-gaap Assets
Assets
4571089 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1134243 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1419699 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
742201 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
555950 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
1553929 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
975000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9890 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38047 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3440263 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2988696 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
150000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
150000 usd
CY2024Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
322125 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
557250 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
61179 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
61179 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
533304 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
768429 usd
CY2024Q3 us-gaap Liabilities
Liabilities
3973567 usd
CY2023Q4 us-gaap Liabilities
Liabilities
3757125 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5825 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5825 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
2 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39968593 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39968593 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35331036 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35331036 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
3997 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3533 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
102142641 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91666691 usd
CY2024Q3 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
2100000 usd
CY2023Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
3500000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-95221907 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
4824733 usd
CY2024Q3 us-gaap Minority Interest
MinorityInterest
157684 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4982417 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8955984 usd
CY2024Q3 us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
0 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
811784 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5072938 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1987670 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5654897 usd
CY2024Q3 us-gaap Salaries And Wages
SalariesAndWages
378740 usd
CY2023Q3 us-gaap Salaries And Wages
SalariesAndWages
379357 usd
us-gaap Salaries And Wages
SalariesAndWages
1283198 usd
us-gaap Salaries And Wages
SalariesAndWages
1019201 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
250000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
250000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
750000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
750000 usd
CY2024Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
431304 usd
CY2023Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
1801081 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
2476392 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
9651391 usd
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
96888 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
113301 usd
us-gaap Share Based Compensation
ShareBasedCompensation
805347 usd
us-gaap Share Based Compensation
ShareBasedCompensation
348993 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
173073 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
272131 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
584667 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
687963 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
0 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12412 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12711 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
2141789 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
7901220 usd
us-gaap Operating Expenses
OperatingExpenses
7892274 usd
us-gaap Operating Expenses
OperatingExpenses
18125156 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2141789 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7901220 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-7892274 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-18125156 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
50926 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
19800 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
317487 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
93853 usd
CY2024Q3 us-gaap Royalty Expense
RoyaltyExpense
-0 usd
CY2023Q3 us-gaap Royalty Expense
RoyaltyExpense
15000 usd
us-gaap Royalty Expense
RoyaltyExpense
-0 usd
us-gaap Royalty Expense
RoyaltyExpense
15000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
51558 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-23601 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
146246 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-23566 usd
CY2024Q3 us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
37257 usd
CY2023Q3 us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
-0 usd
us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
37257 usd
us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
-0 usd
CY2024Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
349500 usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1609125 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
235125 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
746625 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
312875 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
614206 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6350494 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17510948 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-1828914 usd
us-gaap Profit Loss
ProfitLoss
-17510948 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-17510948 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.76
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.76
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39806505 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39806505 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26650210 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26650210 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37640436 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37640436 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22957402 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22957402 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4453329 usd
CY2023Q1 coep Stock Issued During Period Value Issued Subscribed For Non Employee Services
StockIssuedDuringPeriodValueIssuedSubscribedForNonEmployeeServices
3116814 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1111706 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
122391 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-7957833 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
846407 usd
CY2023Q2 coep Stock Issued During Period Value Issued Subscribed For Non Employee Services
StockIssuedDuringPeriodValueIssuedSubscribedForNonEmployeeServices
351000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
811500 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
113301 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3040861 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3202620 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1960449 usd
CY2023Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
500000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
531800 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
514819 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
113301 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
75 usd
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
302926 usd
CY2023Q3 coep Shares Issued In Connection With Asset Purchase Agreement
SharesIssuedInConnectionWithAssetPurchaseAgreement
4320000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-6350494 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1892873 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
813964 usd
CY2024Q1 coep Stock Issued During Period Value Issued For Non Employee Services
StockIssuedDuringPeriodValueIssuedForNonEmployeeServices
541750 usd
CY2024Q1 coep Stock Issued During Period Value Warrants Issued For Cash
StockIssuedDuringPeriodValueWarrantsIssuedForCash
500000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
8150 usd
CY2024Q1 coep Warrants Issued In Exchange For Note Receivable Value
WarrantsIssuedInExchangeForNoteReceivableValue
-100000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
96889 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3001388 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1140635 usd
CY2024Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
558350 usd
CY2024Q2 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
952000 usd
CY2024Q2 coep Stock Issued During Period Value Of Preferred Share Offering
StockIssuedDuringPeriodValueOfPreferredShareOffering
1744000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
611570 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-3035345 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-310060 usd
CY2024Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
49500 usd
CY2024Q3 coep Stock Issued During Period Value Of Preferred Share Offering
StockIssuedDuringPeriodValueOfPreferredShareOffering
1475000 usd
CY2024Q3 coep Relief Of Subscription Receivable
ReliefOfSubscriptionReceivable
5500000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
96891 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1828914 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4982417 usd
us-gaap Net Income Loss
NetIncomeLoss
-7865647 usd
us-gaap Net Income Loss
NetIncomeLoss
-17510948 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
750633 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
750927 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
150000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
28018 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
30238 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
235125 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
746625 usd
us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
805347 usd
us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
348993 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1149600 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
3999614 usd
coep Warrants Issued For Services
WarrantsIssuedForServices
8150 usd
coep Warrants Issued For Services
WarrantsIssuedForServices
2438026 usd
coep Loss On Shares Issued For Conversion Of Debt
LossOnSharesIssuedForConversionOfDebt
77250 usd
coep Loss On Shares Issued For Conversion Of Debt
LossOnSharesIssuedForConversionOfDebt
0 usd
coep Shares Issued In Connection With Asset Purchase Agreement
SharesIssuedInConnectionWithAssetPurchaseAgreement
0 usd
coep Shares Issued In Connection With Asset Purchase Agreement
SharesIssuedInConnectionWithAssetPurchaseAgreement
4320000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8075 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-152104 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-833 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-156880 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-76724 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-28157 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-30861 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-285456 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
382983 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
227868 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
387961 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5212743 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5545728 usd
coep Increase In Subscription Receivable In Exchange For Cash
IncreaseInSubscriptionReceivableInExchangeForCash
100000 usd
coep Increase In Subscription Receivable In Exchange For Cash
IncreaseInSubscriptionReceivableInExchangeForCash
-0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-100000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
3218561 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
0 usd
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
3040935 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1850000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
500000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
587500 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
874999 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
500000 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
500000 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4981061 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3165936 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-331682 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2379792 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1469134 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3791302 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1137453 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1411510 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
coep Warrants Issued In Exchange For Subscriptions Receivable
WarrantsIssuedInExchangeForSubscriptionsReceivable
2000000 usd
coep Warrants Issued In Exchange For Subscriptions Receivable
WarrantsIssuedInExchangeForSubscriptionsReceivable
2500000 usd
coep Preferred Stock Issued In Exchange For Subscriptions Receivable
PreferredStockIssuedInExchangeForSubscriptionsReceivable
2100000 usd
coep Preferred Stock Issued In Exchange For Subscriptions Receivable
PreferredStockIssuedInExchangeForSubscriptionsReceivable
0 usd
coep Shares Issued For Conversion Of Debts
SharesIssuedForConversionOfDebts
868750 usd
coep Shares Issued For Conversion Of Debts
SharesIssuedForConversionOfDebts
302926 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_z2EleRrOnLg4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><b><span id="xdx_863_zKhmqKCcLu2d">Use of Estimates</span> –</b> The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"> </p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_84E_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zkgebxMAC1j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><b><span id="xdx_864_zYZ1660RDFlh">Reclassifications</span> – </b>Certain reclassifications were made to the prior condensed consolidated financial statements to conform to the current period presentation. There was no change to the previously reported net loss</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"> </p>
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-95221907 usd
us-gaap Net Income Loss
NetIncomeLoss
-7865647 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1553929 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1687 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
3266 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
145047 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
1703929 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39968593 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39968593 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35331036 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35331036 shares
CY2024Q3 us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
0 usd
us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
0 usd
CY2023Q3 us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
0 usd
us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
0 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
0 usd
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5825 shares
CY2024Q2 coep Investors Shares Description
InvestorsSharesDescription
On June 13, 2024, the Company performed an initial closing and raised $4.3 million in a sale to accredited investors (collectively, the “Series A Investors”) of 4,300 shares of the Company’s series A preferred stock (the “Series A Preferred Stock”), at a purchase price of $1,000 per share, in a financing led by CJC Investment Trust
CY2024Q3 coep Investors Shares Description
InvestorsSharesDescription
On July 31, 2024, the Company performed a second closing as part of its series A preferred stock offering and raised $1.3 million, at a purchase price of $1,000 per share.
CY2024Q3 coep Investors Shares Description
InvestorsSharesDescription
On September 4, 2024, the Company performed a third closing as part of its series A preferred stock offering and raised $225,000, at a purchase price of $1,000 per share. The Series A Investors currently have an aggregate 8.74% non-voting equity ownership interest in the Company’s two newly formed subsidiaries
CY2024Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
1000 shares
CY2024Q3 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
0.40
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
20000000 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
932836 usd
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
17486316 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
13232043 shares
CY2023Q4 coep Warrants Exercisable To Acquire
WarrantsExercisableToAcquire
1200000 shares
CY2023Q4 coep Warrants Exercisable To Acquire Amount
WarrantsExercisableToAcquireAmount
1000000 usd
coep Amendment Decription
AmendmentDecription
The amount of pre-funded warrants exercisable to acquire up to 1,200,000 shares of common stock was amended to 2,000,000 shares of common stock, and the total principal balance of the note agreement was increased from $1,000,000 to $1,100,000.
CY2024Q1 coep Warrants Exercisable To Acquire
WarrantsExercisableToAcquire
4000000 shares
CY2024Q1 coep Warrants Exercisable To Acquire Amount
WarrantsExercisableToAcquireAmount
1900000 usd
CY2024Q3 us-gaap Minority Interest
MinorityInterest
157684 usd
CY2024Q3 us-gaap Other Receivables
OtherReceivables
5700000 usd
CY2024Q3 us-gaap Accelerated Share Repurchases Initial Price Paid Per Share
AcceleratedShareRepurchasesInitialPricePaidPerShare
1.00
CY2024Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
11415 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
33970 usd
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
11250 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
33750 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
11415 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
46046 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
19301 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
76762 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5693 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
71069 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
69554 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9890 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
61179 usd
CY2023Q3 coep Agreement Amendment Fee
AgreementAmendmentFee
2000 usd
CY2024Q3 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0 usd
CY2023Q3 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0 usd
us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0 usd
us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-007980-index-headers.html Edgar Link pending
0001683168-24-007980-index.html Edgar Link pending
0001683168-24-007980.txt Edgar Link pending
0001683168-24-007980-xbrl.zip Edgar Link pending
coep-20240930.xsd Edgar Link pending
coeptis_ex3101.htm Edgar Link pending
coeptis_ex3102.htm Edgar Link pending
coeptis_ex3201.htm Edgar Link pending
coeptis_ex3202.htm Edgar Link pending
coeptis_i10q-093024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
coep-20240930_cal.xml Edgar Link unprocessable
coep-20240930_def.xml Edgar Link unprocessable
coep-20240930_lab.xml Edgar Link unprocessable
coep-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
coeptis_i10q-093024_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending